IMPORTANCE: Levels of high-sensitivity cardiac troponin T (hs-cTnT) predict secondary cardiovascular events in patients with stable coronary heart disease. OBJECTIVES: To determine the association of hs-cTnT levels with structural and functional measures of heart disease and the extent to which these measures explain the relationship between hs-cTnT and secondary events. DESIGN: We measured serum concentrations of hs-cTnT and performed exercise treadmill testing with stress echocardiography in a prospective cohort study of outpatients with coronary heart disease who were enrolled from September 11, 2000, through December 20, 2002, and followed up for a median of 8.2 years. SETTING: Twelve outpatient clinics in the San Francisco Bay Area. PARTICIPANTS: Nine hundred eighty-four patients with stable coronary heart disease. MAIN OUTCOMES AND MEASURES: Cardiovascular events (myocardial infarction, heart failure, or cardiovascular death), determined by review of medical records and death certificates. RESULTS: Of 984 participants, 794 (80.7%) had detectable hs-cTnT levels. At baseline, higher hs-cTnT levels were associated with greater inducible ischemia and worse left ventricular ejection fraction, left atrial function, diastolic function, left ventricular mass, and treadmill exercise capacity. During follow-up, 317 participants (32.2%) experienced a cardiovascular event. After adjustment for clinical risk factors, baseline cardiac structure and function, and other biomarkers (N-terminal portion of the prohormone of brain-type natriuretic peptide and C-reactive protein levels), each doubling in hs-cTnT level remained associated with a 37% higher rate of cardiovascular events (hazard ratio, 1.37 [95% CI, 1.14-1.65]; P = .001). CONCLUSIONS AND RELEVANCE: In outpatients with stable coronary heart disease, higher hs-cTnT levels were associated with multiple abnormalities of cardiac structure and function but remained independently predictive of secondary events. These findings suggest that hs-cTnT levels may detect an element of risk that is not captured by existing measures of cardiac disease severity.
IMPORTANCE: Levels of high-sensitivity cardiac troponin T (hs-cTnT) predict secondary cardiovascular events in patients with stable coronary heart disease. OBJECTIVES: To determine the association of hs-cTnT levels with structural and functional measures of heart disease and the extent to which these measures explain the relationship between hs-cTnT and secondary events. DESIGN: We measured serum concentrations of hs-cTnT and performed exercise treadmill testing with stress echocardiography in a prospective cohort study of outpatients with coronary heart disease who were enrolled from September 11, 2000, through December 20, 2002, and followed up for a median of 8.2 years. SETTING: Twelve outpatient clinics in the San Francisco Bay Area. PARTICIPANTS: Nine hundred eighty-four patients with stable coronary heart disease. MAIN OUTCOMES AND MEASURES: Cardiovascular events (myocardial infarction, heart failure, or cardiovascular death), determined by review of medical records and death certificates. RESULTS: Of 984 participants, 794 (80.7%) had detectable hs-cTnT levels. At baseline, higher hs-cTnT levels were associated with greater inducible ischemia and worse left ventricular ejection fraction, left atrial function, diastolic function, left ventricular mass, and treadmill exercise capacity. During follow-up, 317 participants (32.2%) experienced a cardiovascular event. After adjustment for clinical risk factors, baseline cardiac structure and function, and other biomarkers (N-terminal portion of the prohormone of brain-type natriuretic peptide and C-reactive protein levels), each doubling in hs-cTnT level remained associated with a 37% higher rate of cardiovascular events (hazard ratio, 1.37 [95% CI, 1.14-1.65]; P = .001). CONCLUSIONS AND RELEVANCE: In outpatients with stable coronary heart disease, higher hs-cTnT levels were associated with multiple abnormalities of cardiac structure and function but remained independently predictive of secondary events. These findings suggest that hs-cTnT levels may detect an element of risk that is not captured by existing measures of cardiac disease severity.
Authors: A K Saenger; R Beyrau; S Braun; R Cooray; A Dolci; H Freidank; E Giannitsis; S Gustafson; B Handy; H Katus; S E Melanson; M Panteghini; P Venge; M Zorn; P Jarolim; D Bruton; J Jarausch; A S Jaffe Journal: Clin Chim Acta Date: 2011-01-08 Impact factor: 3.786
Authors: Paul O Collinson; Yen Ming Heung; David Gaze; Frances Boa; Roxy Senior; Robert Christenson; Fred S Apple Journal: Clin Chem Date: 2011-11-18 Impact factor: 8.327
Authors: Justin T Saunders; Vijay Nambi; James A de Lemos; Lloyd E Chambless; Salim S Virani; Eric Boerwinkle; Ron C Hoogeveen; Xiaoxi Liu; Brad C Astor; Thomas H Mosley; Aaron R Folsom; Gerardo Heiss; Josef Coresh; Christie M Ballantyne Journal: Circulation Date: 2011-03-21 Impact factor: 29.690
Authors: Wolfgang Koenig; Lutz P Breitling; Harry Hahmann; Bernd Wüsten; Hermann Brenner; Dietrich Rothenbacher Journal: Clin Chem Date: 2012-05-25 Impact factor: 8.327
Authors: Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey Journal: N Engl J Med Date: 2012-07-05 Impact factor: 91.245
Authors: Petr Jarolim; Brian L Claggett; Michael J Conrad; Myra A Carpenter; Anastasia Ivanova; Andrew G Bostom; John W Kusek; Lawrence G Hunsicker; Paul F Jacques; Lisa Gravens-Mueller; Peter Finn; Scott D Solomon; Daniel E Weiner; Andrew S Levey; Marc A Pfeffer Journal: Transplantation Date: 2017-01 Impact factor: 4.939
Authors: John W McEvoy; Yuan Chen; Vijay Nambi; Christie M Ballantyne; A Richey Sharrett; Lawrence J Appel; Wendy S Post; Roger S Blumenthal; Kunihiro Matsushita; Elizabeth Selvin Journal: Circulation Date: 2015-07-07 Impact factor: 29.690
Authors: Bruno B Lima; Muhammad Hammadah; Jeong Hwan Kim; Irina Uphoff; Amit Shah; Oleksiy Levantsevych; Zakaria Almuwaqqat; Kasra Moazzami; Samaah Sullivan; Laura Ward; Yan Sun; Michael Kutner; Yi-An Ko; David S Sheps; Agim Beshiri; Gillian Murtagh; J Douglas Bremner; Viola Vaccarino; Arshed A Quyyumi Journal: Am J Cardiol Date: 2020-09-15 Impact factor: 2.778
Authors: Nilson T Poppi; Luís H W Gowdak; Luciana O C Dourado; Eduardo L Adam; Thiago N P Leite; Bruno M Mioto; José E Krieger; Luiz A M César; Alexandre C Pereira Journal: Clin Cardiol Date: 2016-10-18 Impact factor: 2.882
Authors: Kristian B Filion; Sunil K Agarwal; Christie M Ballantyne; Maria Eberg; Ron C Hoogeveen; Rachel R Huxley; Laura R Loehr; Vijay Nambi; Elsayed Z Soliman; Alvaro Alonso Journal: Am Heart J Date: 2014-10-22 Impact factor: 4.749
Authors: Caitlin W Hicks; Dan Wang; Natalie R Daya; B Gwen Windham; Christie M Ballantyne; Kunihiro Matsushita; Elizabeth Selvin Journal: Clin Chem Date: 2020-05-01 Impact factor: 8.327